Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression.

Rogers TJ, Christenson JL, Greene LI, O'Neill KI, Williams MM, Gordon MA, Nemkov T, D'Alessandro A, Degala GD, Shin J, Tan AC, Cittelly DM, Lambert JR, Richer JK.

Mol Cancer Res. 2018 Sep 13. doi: 10.1158/1541-7786.MCR-18-0246. [Epub ahead of print]

PMID:
30213797
2.

A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma.

Greene LI, Bruno TC, Christenson JL, D'Alessandro A, Culp-Hill R, Torkko K, Borges VF, Slansky JE, Richer JK.

Mol Cancer Res. 2018 Aug 24. doi: 10.1158/1541-7786.MCR-18-0362. [Epub ahead of print]

PMID:
30143553
3.

Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer.

Christenson JL, Trepel JB, Ali HY, Lee S, Eisner JR, Baskin-Bey ES, Elias AD, Richer JK.

Horm Cancer. 2018 Apr;9(2):82-94. doi: 10.1007/s12672-017-0314-5. Epub 2018 Jan 16. Review.

PMID:
29340907
4.

Androgen Receptor Supports an Anchorage-Independent, Cancer Stem Cell-like Population in Triple-Negative Breast Cancer.

Barton VN, Christenson JL, Gordon MA, Greene LI, Rogers TJ, Butterfield K, Babbs B, Spoelstra NS, D'Amato NC, Elias A, Richer JK.

Cancer Res. 2017 Jul 1;77(13):3455-3466. doi: 10.1158/0008-5472.CAN-16-3240. Epub 2017 May 16.

5.

MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression.

Christenson JL, Butterfield KT, Spoelstra NS, Norris JD, Josan JS, Pollock JA, McDonnell DP, Katzenellenbogen BS, Katzenellenbogen JA, Richer JK.

Horm Cancer. 2017 Apr;8(2):69-77. doi: 10.1007/s12672-017-0285-6. Epub 2017 Feb 13.

6.

Dicer expression in estrogen receptor-positive versus triple-negative breast cancer: an antibody comparison.

Spoelstra NS, Cittelly DM, Christenson JL, Gordon MA, Elias A, Jedlicka P, Richer JK.

Hum Pathol. 2016 Oct;56:40-51. doi: 10.1016/j.humpath.2016.05.014. Epub 2016 May 31.

7.

t-Darpp overexpression in HER2-positive breast cancer confers a survival advantage in lapatinib.

Christenson JL, Denny EC, Kane SE.

Oncotarget. 2015 Oct 20;6(32):33134-45. doi: 10.18632/oncotarget.5311.

8.

Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.

Barton VN, D'Amato NC, Gordon MA, Christenson JL, Elias A, Richer JK.

Horm Cancer. 2015 Dec;6(5-6):206-13. doi: 10.1007/s12672-015-0232-3. Epub 2015 Jul 23. Review.

PMID:
26201402
9.

Darpp-32 and t-Darpp are differentially expressed in normal and malignant mouse mammary tissue.

Christenson JL, Kane SE.

Mol Cancer. 2014 Aug 15;13:192. doi: 10.1186/1476-4598-13-192.

10.

Clinical effect of converting antidepressant therapy from fluoxetine to sertraline.

Haider A, Miller DR, Christenson JL, Cushing AG, Station RD.

Am J Health Syst Pharm. 1995 Jun 15;52(12):1317-9.

PMID:
7656119
11.

Chronic pain: dynamics and treatment strategies.

Christenson JL.

Perspect Psychiatr Care. 1993 Jan-Mar;29(1):13-7.

PMID:
8451159
12.

A residency policy for pregnancy and parental leave.

Chatham-Showalter PE, Christenson JL.

Mil Med. 1989 Nov;154(11):548-50.

PMID:
2511508

Supplemental Content

Loading ...
Support Center